Zurück zu Diagnostik & Biomarker
Diagnostik & Biomarker

HbA1cStudienlage & Dosis

3-Monats-Mittel des Blutzuckers, diabetisches Risiko, Longevity-Marker.

Studien zuletzt aktualisiert

Studienlage in Zahlen

Studien gesamt
1.000
Mit Abstract
47
Meta / Systematic / RCT
152
Häufig zitiert
6
Erscheinungsjahre
1990–2027

HbA1c im Kontext von Diagnostik & Biomarker

Dieses Thema ist Teil unserer Welt „Diagnostik & Biomarker". Dort findest du Methodik, Studienlage und Hebel mit dem größten Effekt — sowie die Reihenfolge, in der sich Hebel sinnvoll aufeinander aufbauen.

Zur Welt Diagnostik & Biomarker

Top-Studien zu HbA1c

Sortiert nach einflussreichen Zitationen (Semantic Scholar) und Erscheinungsjahr.

  1. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence.

    Journal of the American College of Cardiology2010111 einflussreiche Zitationen

    <h4>Objectives</h4>Our objective was to estimate the magnitude of the relative risk (RR) for cardiovascular disease associated with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) from published prospective…

  2. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.

    Cochrane Database Syst Rev2005n=813Meta-Analysis59 einflussreiche Zitationen

    <h4>Background</h4>Alpha-glucosidase inhibitors such as acarbose or miglitol, have the potential to improve glycemic control in type 2 diabetes mellitus. The true value of these agents, especially in relation to diabetes related mortality…

  3. Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents.

    Diabetes care2009n=59E27 einflussreiche Zitationen

    Glucose fluctuations trigger activation of oxidative stress, a main mechanism leading to secondary diabetes complications. We evaluated the relationship between glycemic variability and beta-cell dysfunction. We conducted a cross-sectional…

  4. Association between the Vicious Cycle of Diabetes-Associated Complications and Glycemic Control among the Elderly: A Systematic Review.

    Medicina (Kaunas)2018n=38Systematic Review12 einflussreiche Zitationen

    Background and objectives: Improved quality of life (QoL) and life expectancy of elderly diabetic patients revolves around optimal glycemic control. Inadequate glycemic control may lead to the development of diabetes-associated…

  5. Tele-Cognitive Behavioral Therapy for the Treatment of Diabetes-Related Distress in Individuals With Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

    J Med Internet Res2025n=2.467Meta-Analysis3 einflussreiche Zitationen

    <h4>Background</h4>Diabetes-related distress (DD) is highly prevalent in individuals with diabetes mellitus (DM) and impairs quality of life. Tele-cognitive behavioral therapy (Tele-CBT) shows potential for reducing DM-related…

  6. Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta-analysis of randomised trials.

    Diabetes Obes Metab2026n=482Meta-Analysis2 einflussreiche Zitationen

    <h4>Objectives</h4>To evaluate the efficacy and safety of advancing to higher levels of diabetes technology in older adults with type 1 diabetes (T1D).<h4>Methods</h4>Web of Science, PubMed, Cochrane Library, and SCOPUS were searched.…

  7. Effects of probiotic supplementation on intestinal microbiota in patients with diabetes/prediabetes: a systematic review and meta-analysis of randomized controlled trials.

    Br J Nutr2026n=1.113Meta-Analysis2 einflussreiche Zitationen

    This study systematically evaluates the effects of probiotic interventions on gut microbiota and clinical outcomes in diabetic patients to determine the optimal target population and conditions for effective use, with an emphasis on…

  8. Mediterranean diet for the management of pre-existing metabolic diseases: Evidence from a systematic review and meta-analysis featured in the Italian national guidelines "La Dieta Mediterranea".

    Nutrition2026n=69Meta-Analysis2 einflussreiche Zitationen

    <h4>Background</h4>Metabolic diseases such as obesity, type 2 diabetes mellitus, metabolic syndrome, dyslipidemia, and non-alcoholic fatty liver disease are major contributors to cardiometabolic risk. While the Mediterranean diet (MD) is…

  9. Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

    Nutrients2025n=11Meta-Analysis2 einflussreiche Zitationen

    <b>Background:</b> Type 2 diabetes mellitus (T2DM) is a growing global health challenge requiring effective dietary management strategies. While the Mediterranean diet shows promise for cardiovascular and metabolic health, the last…

  10. Evaluating the endothelial and metabolic effects of CPAP therapy in obstructive sleep apnea patients: Insights from a comprehensive meta-analysis.

    Sleep Med Rev2025Meta-Analysis2 einflussreiche Zitationen

    Across a growing body of research, continuous positive airway pressure (CPAP) therapy has been consistently explored as a treatment for obstructive sleep apnea (OSA) due to its potential to mitigate vascular and metabolic risk factors.…

Häufige Fragen

Welche Dosierung wurde in den Studien untersucht?
• Alpha-glucosidase inhibitors (acarbose, miglitol, voglibose) as monotherapy (Acarbose dosages higher than 50 mg TID; other doses not specified)
Für welche Population gilt die Evidenz?
Die meisten Studien untersuchten: unknown.
Gibt es Sicherheitshinweise zu HbA1c?
• Adverse effects were mostly gastrointestinal. • Adverse effects were dose dependent. • Acarbose caused more adverse effects than sulphonylurea. • Acarbose doses higher than 50 mg TID added adverse effects without extra HbA1c benefit.

Verwandte Artikel

Weitere Themen in Diagnostik & Biomarker

Blutzucker

Nüchtern, postprandial, Glukoseschwankungen — Grundlage für metabolische Gesundheit.

Blutdruck-Tracking

Häusliche Messung, 24h-Messung, Weißkittelhypertonie.

Körpertemperatur-Tracking

Basaltemperatur, Zyklus, Krankheit, Schlafphasen via Wearable.

Blutbild

Kleines/großes Blutbild, Erythrozyten, Leukozyten, Thrombozyten — Standardpanel.

CGM

Echtzeit-Blutzucker via Sensor — Lernkurve und Limitationen.

Zyklus-Tracking

Menstruationszyklus, Symptome, Fertilität — Apps und Wearables.

Insulin & HOMA-IR

Insulinresistenz früh erkennen — wichtiger als HbA1c bei Risiko-Patienten.

Geroscience Biomarkers

Automatisch via Trend Scout entdeckt. Aging biomarkers and biological clocks are central to longevity interventions and geroscience research.. PubMed: 479 Ergebnisse.

Homocystein

Methylierungs-Marker, kardiovaskuläres und neurologisches Risiko.

HRV-Tracking

Herzratenvariabilität als Resilienz- und Erholungs-Indikator.

Entzündungsmarker

hs-CRP, IL-6, Fibrinogen — chronische niedriggradige Entzündung als Risikofaktor.

Nierenwerte

Kreatinin, Harnstoff, eGFR, Cystatin C — Nierenfunktion bewerten.

Lipidprofil

LDL-C, HDL, Triglyceride, ApoB — moderne kardiovaskuläre Risiko-Bewertung.

Leberwerte

ALT, AST, GGT, Bilirubin — was hohe Werte bedeuten und wann sie ein Problem sind.

Stimmungstracking

Daily Mood Logging, Korrelationen mit Schlaf/Bewegung/Ernährung.

Ernährungstracking

Cronometer, MyFitnessPal, Makros & Mikros, Limitationen.

Ruhepuls

Trend-Marker für kardiovaskuläre Fitness und Übertraining.

Schilddrüsenwerte

TSH, fT3, fT4, ggf. reverse T3 und Antikörper — vollständiges Schilddrüsen-Panel.

VO2max

Maximale Sauerstoffaufnahme — stärkster Longevity-Prädiktor.

Wearables

Übersicht: Oura, Whoop, Apple Watch, Garmin, Fitbit — Vor- und Nachteile.

Verwandte Themen aus anderen Welten